Amedica announced preliminary 2016 revenue of US $15.2MM, -22.2% vs. 2015, and 4Q16 revenue of $3.6MM, -30.5% vs. 4Q15.
The company continues to assess potential impairment related to certain of its long-lived assets before filing its Annual Report for 2016 and Form 10-Q for 1Q17.
To date, the Taurus™ Pedicle Screw has completed >60 surgeries since initial launch in 1Q17, generating $0.45MM in new revenue with 10 new surgeons trialing. Beta launch is slated for mid-summer 2017.
Amedica has entered purchasing agreements for Valeo® silicon nitride spine implants with multiple national and regional hospital groups in the U.S.
Other highlights include:
12% increase in surgeons users vs. end of 2016
10% increase in sales agents vs. end of 2016
Multi-center retrospective >1,000 patient clinical study initiated with long-term surgeon users of silicon nitride
Exhaustive 2017 audit of Quality and Regulatory systems by FDA and Brazil’s ANVISA indicated full compliance
Ongoing metal-ceramic brazing project with a global ceramics manufacturer continues, targeting the total knee market and composite devices for spine
Amedica announced preliminary 2016 revenue of US $15.2MM, -22.2% vs. 2015, and 4Q16 revenue of $3.6MM, -30.5% vs. 4Q15.
The company continues to assess potential impairment related to certain of its long-lived assets before filing its Annual Report for 2016 and Form 10-Q for 1Q17.
To date, the Taurus™ Pedicle Screw has completed >60...
Amedica announced preliminary 2016 revenue of US $15.2MM, -22.2% vs. 2015, and 4Q16 revenue of $3.6MM, -30.5% vs. 4Q15.
The company continues to assess potential impairment related to certain of its long-lived assets before filing its Annual Report for 2016 and Form 10-Q for 1Q17.
To date, the Taurus™ Pedicle Screw has completed >60 surgeries since initial launch in 1Q17, generating $0.45MM in new revenue with 10 new surgeons trialing. Beta launch is slated for mid-summer 2017.
Amedica has entered purchasing agreements for Valeo® silicon nitride spine implants with multiple national and regional hospital groups in the U.S.
Other highlights include:
12% increase in surgeons users vs. end of 2016
10% increase in sales agents vs. end of 2016
Multi-center retrospective >1,000 patient clinical study initiated with long-term surgeon users of silicon nitride
Exhaustive 2017 audit of Quality and Regulatory systems by FDA and Brazil’s ANVISA indicated full compliance
Ongoing metal-ceramic brazing project with a global ceramics manufacturer continues, targeting the total knee market and composite devices for spine
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
